カテゴリー： QYResearch, 世界, 医療/バイオ

世界の次世代配列プラットフォーム市場インサイト及び予測（全エクソーム配列、全ゲノム配列、その他）

◆英語タイトル：Global Next Generation Sequencing Platform Market Insights, Forecast to 2028
	◆商品コード：QY22JLX09884 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：119 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、次世代配列プラットフォームのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に次世代配列プラットフォームの世界市場のxxx％を占める「全エクソーム配列」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院＆診療所」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
次世代配列プラットフォームの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの次世代配列プラットフォーム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

次世代配列プラットフォームのグローバル主要企業には、Illumina、Thermo Fisher Scientific、Beckman Coulter、Roche Sequencing、Eurofins Scientific、Bio-Rad Laboratories、Beijing Berry Genomics、Helicos、Macrogen、BGI、PerkinElmer、Genewiz、Takara Bio、SciGenom Labs、Novogene、Personalisなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

次世代配列プラットフォーム市場は、種類と用途によって区分されます。世界の次世代配列プラットフォーム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
全エクソーム配列、全ゲノム配列、その他

【用途別セグメント】
病院＆診療所、学術＆研究機関、製薬＆バイオテクノロジー企業、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 次世代配列プラットフォーム製品概要
- 種類別市場（全エクソーム配列、全ゲノム配列、その他）
- 用途別市場（病院＆診療所、学術＆研究機関、製薬＆バイオテクノロジー企業、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の次世代配列プラットフォーム販売量予測2017-2028
- 世界の次世代配列プラットフォーム売上予測2017-2028
- 次世代配列プラットフォームの地域別販売量
- 次世代配列プラットフォームの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別次世代配列プラットフォーム販売量
- 主要メーカー別次世代配列プラットフォーム売上
- 主要メーカー別次世代配列プラットフォーム価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（全エクソーム配列、全ゲノム配列、その他）
- 次世代配列プラットフォームの種類別販売量
- 次世代配列プラットフォームの種類別売上
- 次世代配列プラットフォームの種類別価格
・用途別市場規模（病院＆診療所、学術＆研究機関、製薬＆バイオテクノロジー企業、その他）
- 次世代配列プラットフォームの用途別販売量
- 次世代配列プラットフォームの用途別売上
- 次世代配列プラットフォームの用途別価格
・北米市場
- 北米の次世代配列プラットフォーム市場規模（種類別、用途別）
- 主要国別の次世代配列プラットフォーム市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの次世代配列プラットフォーム市場規模（種類別、用途別）
- 主要国別の次世代配列プラットフォーム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の次世代配列プラットフォーム市場規模（種類別、用途別）
- 主要国別の次世代配列プラットフォーム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の次世代配列プラットフォーム市場規模（種類別、用途別）
- 主要国別の次世代配列プラットフォーム市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの次世代配列プラットフォーム市場規模（種類別、用途別）
- 主要国別の次世代配列プラットフォーム市場規模（トルコ、サウジアラビア）
・企業情報
Illumina、Thermo Fisher Scientific、Beckman Coulter、Roche Sequencing、Eurofins Scientific、Bio-Rad Laboratories、Beijing Berry Genomics、Helicos、Macrogen、BGI、PerkinElmer、Genewiz、Takara Bio、SciGenom Labs、Novogene、Personalis
・産業チェーン及び販売チャネル分析
- 次世代配列プラットフォームの産業チェーン分析
- 次世代配列プラットフォームの原材料
- 次世代配列プラットフォームの生産プロセス
- 次世代配列プラットフォームの販売及びマーケティング
- 次世代配列プラットフォームの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 次世代配列プラットフォームの産業動向
- 次世代配列プラットフォームのマーケットドライバー
- 次世代配列プラットフォームの課題
- 次世代配列プラットフォームの阻害要因
・主な調査結果

Next-generation sequencing (NGS) is a massively parallel sequencing technology that offers ultra-high throughput, scalability, and speed. The technology is used to determine the order of nucleotides in entire genomes or targeted regions of DNA or RNA.
Market Analysis and Insights: Global Next Generation Sequencing Platform Market
The global Next Generation Sequencing Platform market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Whole Exome Sequencing accounting for % of the Next Generation Sequencing Platform global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals and Clinics segment is altered to an % CAGR throughout this forecast period.
China Next Generation Sequencing Platform market size is valued at US$ million in 2021, while the North America and Europe Next Generation Sequencing Platform are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Next Generation Sequencing Platform landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Next Generation Sequencing Platform market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Next Generation Sequencing Platform market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Next Generation Sequencing Platform market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Next Generation Sequencing Platform market.
Global Next Generation Sequencing Platform Scope and Market Size
Next Generation Sequencing Platform market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Next Generation Sequencing Platform market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Whole Exome Sequencing
Whole Genome Sequencing
Others
Segment by Application
Hospitals and Clinics
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Others
By Company
Illumina
Thermo Fisher Scientific
Beckman Coulter
Roche Sequencing
Eurofins Scientific
Bio-Rad Laboratories
Beijing Berry Genomics
Helicos
Macrogen
BGI
PerkinElmer
Genewiz
Takara Bio
SciGenom Labs
Novogene
Personalis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Sequencing Platform Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Whole Exome Sequencing
1.2.3 Whole Genome Sequencing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Next Generation Sequencing Platform Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Academic & Research Institutes
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Sequencing Platform Market Perspective (2017-2028)
2.2 Next Generation Sequencing Platform Growth Trends by Region
2.2.1 Next Generation Sequencing Platform Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Next Generation Sequencing Platform Historic Market Size by Region (2017-2022)
2.2.3 Next Generation Sequencing Platform Forecasted Market Size by Region (2023-2028)
2.3 Next Generation Sequencing Platform Market Dynamics
2.3.1 Next Generation Sequencing Platform Industry Trends
2.3.2 Next Generation Sequencing Platform Market Drivers
2.3.3 Next Generation Sequencing Platform Market Challenges
2.3.4 Next Generation Sequencing Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Sequencing Platform Players by Revenue
3.1.1 Global Top Next Generation Sequencing Platform Players by Revenue (2017-2022)
3.1.2 Global Next Generation Sequencing Platform Revenue Market Share by Players (2017-2022)
3.2 Global Next Generation Sequencing Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Sequencing Platform Revenue
3.4 Global Next Generation Sequencing Platform Market Concentration Ratio
3.4.1 Global Next Generation Sequencing Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing Platform Revenue in 2021
3.5 Next Generation Sequencing Platform Key Players Head office and Area Served
3.6 Key Players Next Generation Sequencing Platform Product Solution and Service
3.7 Date of Enter into Next Generation Sequencing Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Sequencing Platform Breakdown Data by Type
4.1 Global Next Generation Sequencing Platform Historic Market Size by Type (2017-2022)
4.2 Global Next Generation Sequencing Platform Forecasted Market Size by Type (2023-2028)
5 Next Generation Sequencing Platform Breakdown Data by Application
5.1 Global Next Generation Sequencing Platform Historic Market Size by Application (2017-2022)
5.2 Global Next Generation Sequencing Platform Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Next Generation Sequencing Platform Market Size (2017-2028)
6.2 North America Next Generation Sequencing Platform Market Size by Type
6.2.1 North America Next Generation Sequencing Platform Market Size by Type (2017-2022)
6.2.2 North America Next Generation Sequencing Platform Market Size by Type (2023-2028)
6.2.3 North America Next Generation Sequencing Platform Market Share by Type (2017-2028)
6.3 North America Next Generation Sequencing Platform Market Size by Application
6.3.1 North America Next Generation Sequencing Platform Market Size by Application (2017-2022)
6.3.2 North America Next Generation Sequencing Platform Market Size by Application (2023-2028)
6.3.3 North America Next Generation Sequencing Platform Market Share by Application (2017-2028)
6.4 North America Next Generation Sequencing Platform Market Size by Country
6.4.1 North America Next Generation Sequencing Platform Market Size by Country (2017-2022)
6.4.2 North America Next Generation Sequencing Platform Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Next Generation Sequencing Platform Market Size (2017-2028)
7.2 Europe Next Generation Sequencing Platform Market Size by Type
7.2.1 Europe Next Generation Sequencing Platform Market Size by Type (2017-2022)
7.2.2 Europe Next Generation Sequencing Platform Market Size by Type (2023-2028)
7.2.3 Europe Next Generation Sequencing Platform Market Share by Type (2017-2028)
7.3 Europe Next Generation Sequencing Platform Market Size by Application
7.3.1 Europe Next Generation Sequencing Platform Market Size by Application (2017-2022)
7.3.2 Europe Next Generation Sequencing Platform Market Size by Application (2023-2028)
7.3.3 Europe Next Generation Sequencing Platform Market Share by Application (2017-2028)
7.4 Europe Next Generation Sequencing Platform Market Size by Country
7.4.1 Europe Next Generation Sequencing Platform Market Size by Country (2017-2022)
7.4.2 Europe Next Generation Sequencing Platform Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencing Platform Market Size (2017-2028)
8.2 Asia-Pacific Next Generation Sequencing Platform Market Size by Type
8.2.1 Asia-Pacific Next Generation Sequencing Platform Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Next Generation Sequencing Platform Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Next Generation Sequencing Platform Market Share by Type (2017-2028)
8.3 Asia-Pacific Next Generation Sequencing Platform Market Size by Application
8.3.1 Asia-Pacific Next Generation Sequencing Platform Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Next Generation Sequencing Platform Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Next Generation Sequencing Platform Market Share by Application (2017-2028)
8.4 Asia-Pacific Next Generation Sequencing Platform Market Size by Region
8.4.1 Asia-Pacific Next Generation Sequencing Platform Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Next Generation Sequencing Platform Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Next Generation Sequencing Platform Market Size (2017-2028)
9.2 Latin America Next Generation Sequencing Platform Market Size by Type
9.2.1 Latin America Next Generation Sequencing Platform Market Size by Type (2017-2022)
9.2.2 Latin America Next Generation Sequencing Platform Market Size by Type (2023-2028)
9.2.3 Latin America Next Generation Sequencing Platform Market Share by Type (2017-2028)
9.3 Latin America Next Generation Sequencing Platform Market Size by Application
9.3.1 Latin America Next Generation Sequencing Platform Market Size by Application (2017-2022)
9.3.2 Latin America Next Generation Sequencing Platform Market Size by Application (2023-2028)
9.3.3 Latin America Next Generation Sequencing Platform Market Share by Application (2017-2028)
9.4 Latin America Next Generation Sequencing Platform Market Size by Country
9.4.1 Latin America Next Generation Sequencing Platform Market Size by Country (2017-2022)
9.4.2 Latin America Next Generation Sequencing Platform Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencing Platform Market Size (2017-2028)
10.2 Middle East & Africa Next Generation Sequencing Platform Market Size by Type
10.2.1 Middle East & Africa Next Generation Sequencing Platform Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Next Generation Sequencing Platform Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Next Generation Sequencing Platform Market Share by Type (2017-2028)
10.3 Middle East & Africa Next Generation Sequencing Platform Market Size by Application
10.3.1 Middle East & Africa Next Generation Sequencing Platform Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Next Generation Sequencing Platform Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Next Generation Sequencing Platform Market Share by Application (2017-2028)
10.4 Middle East & Africa Next Generation Sequencing Platform Market Size by Country
10.4.1 Middle East & Africa Next Generation Sequencing Platform Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Next Generation Sequencing Platform Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Next Generation Sequencing Platform Introduction
11.1.4 Illumina Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.1.5 Illumina Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Next Generation Sequencing Platform Introduction
11.2.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Details
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Next Generation Sequencing Platform Introduction
11.3.4 Beckman Coulter Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.3.5 Beckman Coulter Recent Developments
11.4 Roche Sequencing
11.4.1 Roche Sequencing Company Details
11.4.2 Roche Sequencing Business Overview
11.4.3 Roche Sequencing Next Generation Sequencing Platform Introduction
11.4.4 Roche Sequencing Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.4.5 Roche Sequencing Recent Developments
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Next Generation Sequencing Platform Introduction
11.5.4 Eurofins Scientific Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.5.5 Eurofins Scientific Recent Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Next Generation Sequencing Platform Introduction
11.6.4 Bio-Rad Laboratories Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.6.5 Bio-Rad Laboratories Recent Developments
11.7 Beijing Berry Genomics
11.7.1 Beijing Berry Genomics Company Details
11.7.2 Beijing Berry Genomics Business Overview
11.7.3 Beijing Berry Genomics Next Generation Sequencing Platform Introduction
11.7.4 Beijing Berry Genomics Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.7.5 Beijing Berry Genomics Recent Developments
11.8 Helicos
11.8.1 Helicos Company Details
11.8.2 Helicos Business Overview
11.8.3 Helicos Next Generation Sequencing Platform Introduction
11.8.4 Helicos Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.8.5 Helicos Recent Developments
11.9 Macrogen
11.9.1 Macrogen Company Details
11.9.2 Macrogen Business Overview
11.9.3 Macrogen Next Generation Sequencing Platform Introduction
11.9.4 Macrogen Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.9.5 Macrogen Recent Developments
11.10 BGI
11.10.1 BGI Company Details
11.10.2 BGI Business Overview
11.10.3 BGI Next Generation Sequencing Platform Introduction
11.10.4 BGI Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.10.5 BGI Recent Developments
11.11 PerkinElmer
11.11.1 PerkinElmer Company Details
11.11.2 PerkinElmer Business Overview
11.11.3 PerkinElmer Next Generation Sequencing Platform Introduction
11.11.4 PerkinElmer Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.11.5 PerkinElmer Recent Developments
11.12 Genewiz
11.12.1 Genewiz Company Details
11.12.2 Genewiz Business Overview
11.12.3 Genewiz Next Generation Sequencing Platform Introduction
11.12.4 Genewiz Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.12.5 Genewiz Recent Developments
11.13 Takara Bio
11.13.1 Takara Bio Company Details
11.13.2 Takara Bio Business Overview
11.13.3 Takara Bio Next Generation Sequencing Platform Introduction
11.13.4 Takara Bio Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.13.5 Takara Bio Recent Developments
11.14 SciGenom Labs
11.14.1 SciGenom Labs Company Details
11.14.2 SciGenom Labs Business Overview
11.14.3 SciGenom Labs Next Generation Sequencing Platform Introduction
11.14.4 SciGenom Labs Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.14.5 SciGenom Labs Recent Developments
11.15 Novogene
11.15.1 Novogene Company Details
11.15.2 Novogene Business Overview
11.15.3 Novogene Next Generation Sequencing Platform Introduction
11.15.4 Novogene Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.15.5 Novogene Recent Developments
11.16 Personalis
11.16.1 Personalis Company Details
11.16.2 Personalis Business Overview
11.16.3 Personalis Next Generation Sequencing Platform Introduction
11.16.4 Personalis Revenue in Next Generation Sequencing Platform Business (2017-2022)
11.16.5 Personalis Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の次世代配列プラットフォーム市場インサイト及び予測（全エクソーム配列、全ゲノム配列、その他）(Global Next Generation Sequencing Platform Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の次世代配列プラットフォーム市場インサイト及び予測（全エクソーム配列、全ゲノム配列、その他）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp